Insulin-Induced Normoglycemia Reduces Islet Number Needed to Achieve Normoglycemia after Allogeneic Islet Transplantation in Diabetic Mice
| Autor: | José Luis Ponce-Marco, Gema Pérez Bermejo, Juan C. Ferrer-Garcı́a, Juan Francisco Merino-Torres, Francisco Pinon-Selles, Carmen Herrera-Vela |
|---|---|
| Předmět: |
0301 basic medicine
Blood Glucose Male endocrine system medicine.medical_specialty Time Factors endocrine system diseases Edmonton protocol medicine.medical_treatment Biomedical Engineering Islets of Langerhans Transplantation lcsh:Medicine Diabetes Mellitus Experimental 03 medical and health sciences Islets of Langerhans Mice 0302 clinical medicine Internal medicine Diabetes mellitus medicine Animals Humans Insulin Transplantation Homologous Transplantation geography Glucose tolerance test geography.geographical_feature_category medicine.diagnostic_test business.industry lcsh:R Cell Biology Hypoxia (medical) Glucose Tolerance Test Streptozotocin Islet medicine.disease 030104 developmental biology Endocrinology medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Scopus-Elsevier Cell Transplantation, Vol 12 (2003) Europe PubMed Central |
| Popis: | The Edmonton protocol established that insulin independence could be reached with the transplantation of an appropriate number of islet cells. However, to effect a cure, islets from two or three pancreases are needed. The aim of this study was to examine whether normoglycemia, with insulin treatment before and after transplantation, reduces the islet number needed to achieve normoglycemia in allogeneic islet transplantation. Swiss mice were used as donors and recipients. Diabetes was induced by IP administration of streptozotocin (180 mg/kg BW). Diabetic mice were transplanted with 300 (n = 16), 400 (n = 16), or 500 (n = 16) islets under the left kidney capsule. For every group, half the animals were kept normoglycemic with insulin treatment from day 4 before transplantation to day 10 after transplantation. At the end of the study, all normoglycemic mice were given an IP glucose tolerance test (IPGTT). For statistical analysis, paired or unpaired Student's t-test or ANOVA was used. Only insulin-treated mice achieved normoglycemia by the end of the study (37.5% of animals transplanted with 400 islets and 50% transplanted with 300 or 500 islets). At the end of the study, normoglycemic mice transplanted with 300 allogeneic islets showed better glycosylated hemoglobin (HbA1C) than did normoglycemic mice transplanted with 500 islets (300 islets: 2.7 ± 0.2%; 500 islets: 3.6 ± 0.2%; p < 0.05). After the IPGTT, insulin-treated mice transplanted with 500 islets showed abnormal glucose tolerance; however, insulin-treated mice transplanted with 300 or 400 islets showed normal glucose tolerance. Insulin treatment reduced the islet number needed to achieve normoglycemia in allogeneic islet transplantation. The HbA1C and IPGTT results suggest that transplanting smaller numbers of allogeneic islets improves β-cell function; some studies suggest that this may be due to lower immunogenicity, hypoxia, and inflammation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|